- 201. flunitrazepam
- [A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. ( MSH )] (UMLS (CSP) C0016296) =Organic Chemical; Pharmacologic Substance ;
| - 250. Fluorouracil/IM-862
- (UMLS (NCI) C0879574) =Therapeutic or Preventive Procedure
|
- 202. FLUNIXIN
- (UMLS (NCI) C0060502) =Organic Chemical; Pharmacologic Substance
| - 251. Fluorouracil/Irinotecan
- (UMLS (NCI) C0935708) =Therapeutic or Preventive Procedure
|
- 203. Flunoxaprofen
- (UMLS (NCI) C0060504) =Organic Chemical; Pharmacologic Substance
| - 252. Fluorouracil/Irinotecan/Leucovorin Calcium/Monoclonal Antibody ABX-EGF
- (UMLS (NCI) C1327789) =Therapeutic or Preventive Procedure ;
|
- 204. Fluor-Op
- (UMLS (NCI) C0720477) =Steroid; Pharmacologic Substance
| - 253. Fluorouracil/irinotecan/leucovorin calcium/oxaliplatin
- (UMLS (NCI) C0879464) =Therapeutic or Preventive Procedure ;
|
- 205. fluorene
- [A family of diphenylenemethane derivatives. ( MSH )] (UMLS (CSP) C0016311) =Organic Chemical; Hazardous or Poisonous Substance ;
=PAH;
=hexafluorenium;
| - 254. Fluorouracil/Irinotecan/Leucovorin Calcium/SU5416
- (UMLS (NCI) C0935893) =Therapeutic or Preventive Procedure
|
- 206. FLUORESCEIN
- [phthalic yellow-green dye used as an indicator and diagnostic aid; used therapeutically as a diagnostic aid in corneal injuries and corneal trauma; also used to label antibodies for fluorescence. ( CSP )] (UMLS (NCI) C0060520) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =benzopyran;
Fluoresceins;
fluorescent dye;
[OP900] OPHTHALMICS, OTHER =Fluorescein Sodium;
| - 255. Fluorouracil/Leucovorin Calcium/Lonafarnib
- (UMLS (NCI) C0796671) =Therapeutic or Preventive Procedure
|
- 207. Fluorescein angiography
- [visualization of a vascular system after intravenous injection of a fluorescein solution; images may be photographed or televised; used especially in studying the retinal and uveal vasculature. ( CSP )] (UMLS (HL7) C0016313) =Diagnostic Procedure =Angiogram;
Modality | - 256. Fluorouracil/Leucovorin Calcium/Oblimersen/Oxaliplatin
- (UMLS (NCI) C1327901) =Therapeutic or Preventive Procedure ;
|
- 208. Fluorescein Angioscopy
- (UMLS (HL7) C1548855) =Health Care Activity =Consent Type;
| - 257. Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787
- (UMLS (NCI) C1328037) Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787(ZK 222584) =Therapeutic or Preventive Procedure; ;
|
- 209. Fluorescein Sodium
- (UMLS (NCI) C0147866) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =FLUORESCEIN;
=FLUORESCEIN SODIUM 0.6 MG;
FLUORESCEIN SODIUM 1 MG;
FLUORESCEIN SODIUM 10 %;
FLUORESCEIN SODIUM 9 MG;
FLUORESCEIN SODIUM 0.25 %;
FLUORESCEIN SODIUM 2 %;
FLUORESCEIN SODIUM 25 % | - 258. Fluorouracil/Leucovorin Calcium/Oxaliplatin/Trastuzumab
- (UMLS (NCI) C0879557) =Therapeutic or Preventive Procedure
|
- 210. fluorescence
- [absorption of a photon of light followed, after a delay, by emission of a photon of longer wavelength. ( CSP )] (UMLS (CSP) C0016315) =Natural Phenomenon or Process =light emission;
| - 259. Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD6126
- (UMLS (NCI) C1328166) =Therapeutic or Preventive Procedure; ;
|
- 211. fluorescence anisotropy
- [ ] (UMLS (CSP) C0085813) =Natural Phenomenon or Process ;
| - 260. Fluorouracil/Leucovorin Calcium/SU5416
- (UMLS (NCI) C0796685) =Therapeutic or Preventive Procedure
|
- 212. Fluorescence Light Microscopy
- [microscope that irradiates fluorescent materials or specimens with ultraviolet, violet, and occasionally blue light, causing the materials to fluoresce. ( CSP )] (UMLS (NCI) C0026022) =Laboratory Procedure ;
=microscopy;
| - 261. Fluorouracil/Leucovorin Calcium/Triacetyluridine
- (UMLS (NCI) C0879400) =Therapeutic or Preventive Procedure
|
- 213. fluorescence polarization
- [measurement of the polarization of fluorescent light from solutions or microscopic specimens; used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction. ( CSP )] (UMLS (CSP) C0016316) =Laboratory Procedure =optical polarization;
| - 262. Fluorouracil/Leucovorin Calcium/UCN-01
- (UMLS (NCI) C1327740) =Therapeutic or Preventive Procedure ;
|
- 214. Fluorescence polarization immunoassay (FPIA)
- [Immunoassay, Fluorescence Polarization ( HL7V3.0 )] (UMLS (HL7) C0079365) =Laboratory Procedure ;
=ObservationMethod;
| - 263. Fluorouracil/UCN-01
- (UMLS (NCI) C0879295) =Therapeutic or Preventive Procedure
|
- 215. fluorescence recovery after photobleaching
- [method used to study lateral movements of membrane proteins and lipids; a small area of a cell membrane is bleached by laser light and the amount of time necessary for unbleached fluorescent marker tagged proteins to diffuse back into the bleached site is a measurement of the cell membrane's fluidity. ( CSP )] (UMLS (CSP) C1138405) FRAP;
FRAP (fluorescence recovery after photobleaching);
=Laboratory Procedure ;
=fluorimetry;
| - 264. Fluorouracil/Vincristine
- (UMLS (NCI) C0879260) =Therapeutic or Preventive Procedure
|
- 216. fluorescence resonance energy transfer
- [method used to evaluate interactions and different conformational states of molecules. ( CSP )] (UMLS (CSP) C0597717) =Laboratory Procedure ;
=fluorescence spectrometry;
| - 265. Fluorouracil/Virulizin
- (UMLS (NCI) C1327757) =Therapeutic or Preventive Procedure; ;
|
- 217. fluorescence spectrometry
- [measurement of the intensity and quality of fluorescence ( CSP )] (UMLS (CSP) C0037802) =Laboratory Procedure ;
=fluorimetry;
=fluorescence resonance energy transfer | - 266. Fluosol-DA
- [A perfluorocarbon blood substitute in trials for the treatment of severe anemia ( NCI )] (UMLS (NCI) C0060574) =Organic Chemical; Pharmacologic Substance
|
- 218. fluorescence spectrophotometry
- [ ] (UMLS (CSP) C0242505) =Laboratory Procedure ;
| - 267. Fluoxamine
- [A 2-aminoethyl oxime ether of aralkylketones, with antidepressant, antiobsessive-compulsive, and anxiolytic properties. Fluvoxamine, chemically unrelated to other selective serotonin reuptake inhibitors, selectively blocks serotonin reuptake by inhibiting the serotonin reuptake pump at the presynaptic neuronal membrane. This increases serotonin levels within the synaptic cleft, prolongs serotonergic transmission and decreased serotonin turnover, thereby leading to antidepressant, anxiolytic and antiobsessive-compulsive effects. Fluvoxamine shows no significant affinity for histaminergic, alpha or beta adrenergic, muscarinic, or dopaminergic receptors in vitro. ( NCI )] (UMLS (NCI) C0085228) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
oxime;
serotonin inhibitor;
[CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS;
[CN609] ANTIDEPRESSANTS, OTHER;
=FLUVOXAMINE MALEATE |
- 219. fluorescence spectroscopy
- [Fluorescent spectroscopy or fluorometry is a type of electromagnetic spectroscopy used for analyzing fluorescent spectra. It involves using a beam of light, usually ultraviolet light, that excites the electrons in molecules of certain compounds and causes them to emit light of a lower energy, typically, but not necessarily, visible light. ( NCI )] (UMLS (CSP) C0242506) =Laboratory Procedure ;
| - 268. FLUOXETINE
- [N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine; used in the treatment of depression; action thought to be linked to its inhibition of CNS neuronal uptake of serotonin. ( CSP )] (UMLS (NCI) C0016365) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
Propylamines;
serotonin inhibitor;
phenylalkoxyalkylamine;
[CN609] ANTIDEPRESSANTS, OTHER;
=FLUOXETINE HYDROCHLORIDE;
FLUOXETINE 10 MG;
FLUOXETINE 40 MG;
|
- 220. fluorescent antibody
- [any immunohistochemical method using antibody labeled with a fluorescent dye and frequently examined by fluorescence microscopy. ( CSP )] (UMLS (CSP) C0016318) =Laboratory Procedure =immunocytochemistry;
| - 269. Fluoxymesterone/Tamoxifen
- (UMLS (NCI) C0280900) =Therapeutic or Preventive Procedure
|
- 221. fluorescent dye
- [dyes that emit light when exposed to light; the wave length of the emitted light is usually longer than that of the incident light; fluorochromes are substances that cause fluorescence in other substances, that is, dyes used to mark or label other compounds with fluorescent tags, and they are used as markers in biochemistry and immunology. ( CSP )] (UMLS (CSP) C0016320) =Indicator, Reagent, or Diagnostic Aid =dye;
=ethidium;
FLUORESCEIN;
radiofluorescent probe;
| - 270. Fluphenazine Enanthate
- (UMLS (NCI) C0066682) =Organic Chemical; Pharmacologic Substance =1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
=FLUPHENAZINE ENANTHATE 25 MG/ML |
- 222. fluorescent probe
- [ ] (UMLS (CSP) C0016321) =Indicator, Reagent, or Diagnostic Aid
| - 271. Fluprazine
- (UMLS (NCI) C0117988) =Organic Chemical; Pharmacologic Substance ;
|
- 223. Fluoresone
- (UMLS (NCI) C0619286) =Organic Chemical
| - 272. FLUPREDNISOLONE
- [A synthetic glucocorticoid with anti-inflammatory properties. ( MSH )] (UMLS (NCI) C0016369) =Steroid; Pharmacologic Substance; Hormone
|
- 224. fluoridation
- [incorporation or addition of fluoride in a compound. ( CSP )] (UMLS (CSP) C0687703) =Natural Phenomenon or Process ;
=halogenation;
| - 273. Fluprowit
- (UMLS (NCI) C1449419) Muco Sanigen;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance |
- 225. fluorimetry
- [the measurement of fluorescence. ( CSP )] (UMLS (CSP) C0016352) =Laboratory Procedure =spectrometry;
=fluorescence spectrometry;
fluorescence recovery after photobleaching | - 274. FLURAZEPAM
- [benzodiazepine derivative used mainly as a sedative and hypnotic in the treatment of insomnia. ( CSP )] (UMLS (NCI) C0016375) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
benzodiazepine;
Benzodiazepinones;
[CN300] SEDATIVES/HYPNOTICS;
Muscle Relaxant;
[CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS =FLURAZEPAM HYDROCHLORIDE;
|
- 226. fluoro fatty acid
- [ ] (UMLS (CSP) C0598430) =Lipid ;
| - 275. Flurithromycin
- (UMLS (NCI) C0060591) =Organic Chemical; Antibiotic
|
- 227. fluoroaminoacid
- [amino acid containing fluoride. ( CSP )] (UMLS (CSP) C0596580) =Amino Acid, Peptide, or Protein ;
=haloaminoacid;
=2-(Difluoromethyl)-DL-ornithine | - 276. Flurizan
- (UMLS (NCI) C1327755) =Organic Chemical; Pharmacologic Substance
|
- 228. fluorocarbon polymer
- [dense, inert resin made up of carbon and fluorine, with or without other halogens or hydrogen. ( CSP )] (UMLS (CSP) C0016337) =Organic Chemical =fluorohydrocarbon;
plastic | - 277. fluroxene
- [ ] (UMLS (CSP) C0016381) =Organic Chemical; Pharmacologic Substance ;
|
- 229. fluorocarbon respiratory assist
- [ ] (UMLS (CSP) C0599337) =Therapeutic or Preventive Procedure ;
| - 278. Flush
- [Flush ( HL7V3.0 )] (UMLS (HL7) C1696091) =Functional Concept =RouteByMethod;
=Flush, intravenous catheter;
|
- 230. Fluorocarbons
- [Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes. ( MSH )] (UMLS (HL7) C0016340) =Organic Chemical =artificial blood;
fluorohydrocarbon =perfluorodecalin;
Perflubron | - 279. Flush, intravenous catheter
- [Flush, intravenous catheter ( HL7V3.0 )] (UMLS (HL7) C1553213) =Functional Concept =IntravenousRoute;
Flush |
- 231. Fluorochrome
- [A class of dyes when excited by light of certain wavelengths, emit photons and become fluorescent. Fluorescence gives fluorochromes imaging characteristics and are used to label or stain biological structures. ( NCI )] (UMLS (NCI) C0016342) =Indicator, Reagent, or Diagnostic Aid
| - 280. FLUSHING
- [A sudden reddening of the face. ( NCI )] (UMLS (ICD9CM) C0016382) =Sign or Symptom =Clinical Finding;
|
- 232. fluorodeoxyglucose
- [ ] (UMLS (CSP) C0872172) =Carbohydrate; Pharmacologic Substance
| - 281. FLUT/KCZ
- (UMLS (NCI) C0281151) =Therapeutic or Preventive Procedure ;
|
- 233. fluorodiazepam
- [ ] (UMLS (CSP) C0598453) =Organic Chemical
| - 282. FLUT/KCZ/LEUP
- (UMLS (NCI) C0281150) =Therapeutic or Preventive Procedure ;
|
- 234. Fluorodopan
- [An alkylating agent with potential antineoplastic activity. Fluorodopan alkylates DNA at the N7 position of guanine. Alkylating agents exert cytotoxic and, in some cases, chemotherapeutic effects by transferring alkyl groups to DNA, thereby damaging DNA and interfering with DNA replication and cell division. (NCI04) ( NCI )] (UMLS (NCI) C0060560) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 283. FLUT/LEUP
- (UMLS (NCI) C0280778) =Therapeutic or Preventive Procedure
|
- 235. fluorohydrocarbon
- [organic compound that contains carbon and hydrogen, with fluorine atoms substituting for one or more hydrogens. ( CSP )] (UMLS (CSP) C0020249) =Organic Chemical =Halogenated Hydrocarbon;
=fluorocarbon polymer;
fluosol;
Fluorocarbons;
Chlorofluorocarbons;
| - 284. FLUT/LEUP/somatuline/SUR
- (UMLS (NCI) C0281028) =Therapeutic or Preventive Procedure
|
- 236. FLUOROMETHOLONE
- [A synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Fluorometholone exerts its effects by interacting with cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. ( NCI )] (UMLS (NCI) C0016351) =Steroid; Pharmacologic Substance ;
=Pregnadienediols;
Steroids, Fluorinated;
[OP300] ANTI-INFLAMMATORIES, TOPICAL OPHTHALMIC;
=9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate;
FLUOROMETHOLONE 0.1 % | - 285. FLUT/LEUP/SUR
- (UMLS (NCI) C0280880) =Therapeutic or Preventive Procedure
|
- 237. fluorophore
- [ ] (UMLS (CSP) C0598447) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid ;
| - 286. FLUT/SUR/ZDX
- (UMLS (NCI) C0281616) =Therapeutic or Preventive Procedure
|
- 238. Fluorophotometry
- [Measurement of light given off by fluorescein in order to assess the integrity of various ocular barriers. The method is used to investigate the blood-aqueous barrier, blood-retinal barrier, aqueous flow measurements, corneal endothelial permeability, and tear flow dynamics (From MSH2001). ( NCI )] (UMLS (NCI) C0016353) =Diagnostic Procedure
| - 287. FLUT/TRIP
- (UMLS (NCI) C0796488) Flutamide/Triptorelin;
=Therapeutic or Preventive Procedure ;
|
- 239. Fluoroplex
- (UMLS (NCI) C0699375) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 288. FLUT/ZDX
- (UMLS (NCI) C0278891) =Therapeutic or Preventive Procedure
|
- 240. fluoropyrimidine
- [group of compounds which seem to have antineoplastic activity. ( CSP )] (UMLS (CSP) C0596581) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =pyrimidine analog;
=1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil;
2,4-Dioxo-5-fluoropyrimidine;
5 fluorouridine | - 289. Flutamide/Toremifene
- (UMLS (NCI) C0935888) =Therapeutic or Preventive Procedure
|
- 241. fluoroscope
- [(FLOOR-o-skope) An x-ray machine that makes it possible to see internal organs in motion. ( NCI )] (UMLS (NCI) C0180921) =Medical Device
| - 290. Flutazolam
- (UMLS (NCI) C0060593) =Organic Chemical ;
|
- 242. fluoroscopic image intensifier
- [An image-intensified fluoroscopic X-ray system is a device intended to visualize anatomical structures by converting a pattern of X-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories. ( SPN )] (UMLS (CSP) C0492215) =Medical Device
| - 291. FLUTICASONE
- [A synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Fluticasone binds and activates glucocorticoid receptor, resulting in the activation of lipocortin. Lipocortin, in turn, inhibits cytosolic phospholipase A2, which triggers a cascade of reactions involved in the synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production. ( NCI )] (UMLS (NCI) C0082607) =Organic Chemical; Pharmacologic Substance ;
=Androstadienes;
[NT200] ANTI-INFLAMMATORIES, NASAL;
[RE101] ANTI-INFLAMMATORIES, INHALATION;
=(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester;
FLUTICASONE 100 MCG;
FLUTICASONE 250 MCG;
FLUTICASONE 500 MCG |
- 243. fluoroscopy
- [production of an image when x-rays strike a fluorescent screen. ( CSP )] (UMLS (NCI) C0016356) =Diagnostic Procedure =Endoscopic;
radiography | - 292. Flutonidine
- (UMLS (NCI) C0060595) =Organic Chemical; Pharmacologic Substance
|
- 244. Fluorotestosterone
- [A synthetic nonaromatizable androgen analog of testosterone. Fluorotestosterone (6 alpha-fluorotestosterone) binds to and activates specific nuclear receptors inhibits and is equipotent to testosterone. (NCI04) ( NCI )] (UMLS (NCI) C0049381) =Steroid; Pharmacologic Substance
| - 293. Flutoprazepam
- (UMLS (NCI) C0117998) =Organic Chemical; Pharmacologic Substance
|
- 245. Fluorouracil-Uracil/Gemcitabine/Leucovorin Calcium
- (UMLS (NCI) C0796674) =Therapeutic or Preventive Procedure
| - 294. Flutter, ventricular
- [A ventricular tachyarrhythmia characterized electrocardiographically by smooth undulating waves with QRS complexes merged with T waves, a rate of approximately 250 per minute. ( NCI )] (UMLS (NCI) C0152173) =Pathologic Function
|
- 246. Fluorouracil/Gefitinib/Irinotecan/Leucovorin Calcium
- (UMLS (NCI) C1134514) =Therapeutic or Preventive Procedure
| - 295. FLUVASTATIN
- [A synthetic lipid-lowering agent with antilipidemic and potential antineoplastic properties. Fluvastatin competitively inhibits hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses through the suppression of MHC II (major histocompatibility complex II) on interferon gamma-stimulated antigen-presenting cells such as human vascular endothelial cells. Due to its anti-inflammatory effects mediated by alterations of lipid metabolism, fluvastatin may possess chemopreventive and therapeutic antineoplastic properties. ( NCI )] (UMLS (NCI) C0082608) =Organic Chemical; Pharmacologic Substance ;
=[CV350] ANTILIPEMIC AGENTS;
Fatty Acids, Monounsaturated;
Indole;
=(3R,5S,6E)-(+/-)-7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic Acid;
|
- 247. Fluorouracil/Gefitinib/Leucovorin Calcium/Oxaliplatin
- (UMLS (NCI) C1134492) =Therapeutic or Preventive Procedure
| - 296. flying
- [to move in or pass through the air with wings; this is for the act of movement through air by wings; for transportation by airplane use AVIATION. ( CSP )] (UMLS (CSP) C0677530) =Phenomenon or Process ;
=body movement;
|
- 248. Fluorouracil/Gemcitabine/Oxaliplatin
- (UMLS (NCI) C0879418) =Therapeutic or Preventive Procedure
| - 297. Flying Phobia
- (UMLS (NCI) C0344318) =Mental or Behavioral Dysfunction ;
|
- 249. Fluorouracil/Gemcitabine/Paclitaxel
- (UMLS (NCI) C0879345) =Therapeutic or Preventive Procedure
| - 298. flying squirrel
- [ ] (UMLS (CSP) C1265492) =Mammal
|
home
